ZHONG Jianfeng,SHEN Bin,QIU Jia, et al. Efficacy and Safety of Linezolid Combined with Levofloxacin for Tuberculous Meningitis during the Intensive Phrase of Treatment [J]. Chinese General Practice, 2019, 22(2): 215-219. DOI: 10.12114/j.issn.1007-9572.2018.00.218.
钟剑峰,沈斌,邱佳等. 利奈唑胺联合左氧氟沙星在结核性脑膜炎强化期应用的疗效和安全性研究[J]. 中国全科医学, 2019, 22(2): 215-219. DOI: 10.12114/j.issn.1007-9572.2018.00.218.
[1]World Health Organization.Global tuberculosis report 2017[M].Geneva:World Health Organization,2017.
[2]THWAITES G.Tuberculous meningitis[J].Medicine,2017,45(11):670-673.DOI:10.1016/j.mpmed.2017.08.010.
[3]CHIANG S S,KHAN F A,MILSTEIN M B,et al.Treatment outcomes of childhood tuberculous meningitis:a systematic review and meta-analysis[J].Lancet Infect Dis,2014,14(10):947-957.DOI:10.1016/S1473-3099(14)70852-7.
[4]MARAIS S,PEPPER D J,SCHUTZ C,et al.Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting[J].PLoS One,2011,6(5):e20077.DOI:10.1371/journal.pone.0020077.
[5]World Health Organization.Treatment of tuberculosis:guidelines[M].Geneva:World Health Organization,2010:29-42.
[6]DAVIS A,MEINTJES G,WILKINSON R J.Treatment of tuberculous meningitis and its complications in adults[J].Curr Treat Options Neurol,2018,20(3):5.DOI:10.1007/s11940-018-0490-9.
[7]DONALD P R.Cerebrospinal fluid concentrations of antituberculosis agents in adults and children[J].Tuberculosis(Edinb),2010,90(5):279-292.DOI:10.1016/j.tube.2010.07.002.
[8]周晛,孙峰,张文宏.结核性脑膜炎治疗新策略的研究进展[J].中华临床感染病杂志,2016,9(5):477-480.DOI:10.3760/cma.j.issn.1674-2397.2016.05.023.
ZHOU X,SUN F,ZHANG W H.Progress of antitubercular treatment for tuberculous meningitis[J].Chinese Journal of Clinical Infectious Diseases,2016,9(5):477-480.DOI:10.3760/cma.j.issn.1674-2397.2016.05.023.
[9]中华医学会结核病学分会,利奈唑胺抗结核治疗专家共识编写组.利奈唑胺抗结核治疗专家共识[J].中华结核和呼吸杂志,2018,41(1):14-19.DOI:10.3760/cma.j.issn.1001-0939.2018.01.006.
Chinese Medicine Association Tuberculosis Branch,Linezolid Anti Tuberculosis Treatment Expert Consensus Group.Linezolid expert consensus on anti tuberculosis treatment[J].Chinese Journal of Tuberculosis and Respiratory Diseases,2018,41(1):14-19.DOI:10.3760/cma.j.issn.1001-0939.2018.01.006
[10]THWAITES G E,NGUYEN D B,NGUYEN H D,et al.Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults[J].N Engl J Med,2004,351(17):1741-1751.DOI:10.1056/NEJMoa040573.
[11]THWAITES G E,LAN N T,DUNG N H,et al.Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis[J].J Infect Dis,2005,192(1):79-88.DOI:10.1086/430616.
[12]DUO L,YING B,SONG X,et al.Molecular profile of drug resistance in tuberculous meningitis from southwest china[J].Clin Infect Dis,2011,53(11):1067-1073.DOI:10.1093/cid/cir663.
[13]VINNARD C,KING L,MUNSIFF S,et al.Long-term mortality of patients with tuberculous meningitis in New York City:a cohort study[J].Clin Infect Dis,2017,64(4):401-407.DOI:10.1093/cid/ciw763.
[14]WILKINSON R J,ROHLWINK U,MISRA U K,et al.Tuberculous meningitis[J].Nat Rev Neurol,2017,13(10):581-598.DOI:10.1038/nrneurol.2017.120.
[15]PATEL V B,THERON G,LENDERS L,et al.Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting:a prospective study[J].PLoS Med,2013,10(10):e1001536.DOI:10.1371/journal.pmed.1001536.
[16]NHU N T,HEEMSKERK D,THU DO D A,et al.Evaluation of GeneXpert MTB/RIF for diagnosis of tuberculous meningitis[J].J Clin Microbiol,2014,52(1):226-233.DOI:10.1128/JCM.01834-13.
[17]BAHR N C,MARAIS S,CAWS M,et al.GeneXpert MTB/Rif to diagnose tuberculous meningitis:perhaps the first test but not the last[J].Clin Infect Dis,2016,62(9):1133-1135.DOI:10.1093/cid/ciw083.
[18]BAHR N C,TUGUME L,RAJASINGHAM R,et al.Improved diagnostic sensitivity for tuberculous meningitis with Xpert MTB/RIF of centrifuged CSF[J].Int Tuberc Lung Dis,2015,19(10):1209-1215.DOI:10.5588/ijtld.15.0253.
[19]MAI N T,THWAITES G E.Recent advances in the diagnosis and management of tuberculous meningitis[J].Curr Opin Infect Dis,2017,30(1):123-128.DOI:10.1097/QCO.0000000000000331.
[20]FORTúN J,MARTIN-DáVILA P,NAVAS E,et al.Linezolid for the treatment of multidrug-resistant tuberculosis[J].J Antimicrob Chemother,2005,56(1):180-185.DOI:10.1093/jac/dki148.
[21]VON DER LIPPE B,SANDVEN P,BRUBAKK O.Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)—a report of ten cases[J].J Infect,2006,52(2):92-96.DOI:10.1016/j.jinf.2005.04.007.
[22]SOTGIU G,CENTIS R,D'AMBROSIO L,et al.Efficacy,safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB:systematic review and meta-analysis[J].Eur Respir J,2012,40(6):1430-1442.DOI:10.1183/09031936.00022912.
[23]唐神结,肖和平.利奈唑胺抗结核作用的研究及其最新进展[J].中华临床医师杂志(电子版),2010,4(1):63-66.DOI:10.3969/j.issn.1674-0785.2010.01.013.
TANG S J,XIAO H P.Study on the anti tuberculosis effect of linezolid and its recent progress[J].Chinese Journal of Clinicians(Electronic Edition),2010,4(1):63-66.DOI:10.3969/j.issn.1674-0785.2010.01.013.
[24]MARX G E,CHAN E D.Tuberculous meningitis:diagnosis and treatment overview[J].Tuberc Res Treat,2011:798764.DOI:10.1155/2011/798764.
[25]SUN F,RUAN Q,WANG J,et al.Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis[J].Antimicrob Agents Chemother,2014,58(10):6297-6301.DOI:10.1128/AAC.02784-14.
[26]LI H,LU J,LIU J,et al.Linezolid is associated with improved early outcomes of childhood tuberculous meningitis[J].Pediatr Infect Dis J,2016,35(6):607-610.DOI:10.1097/INF.0000000000001114.
[27]THWAITES G E,BHAVNANI S M,CHAU T T,et al.Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis[J].Antimicrob Agents Chemother,2011,55(7):3244-3253.DOI:10.1128/AAC.00064-11.
[28]HEEMSKERK A D,BANG N D,MAI N T,et al.Intensified antituberculosis therapy in adults with tuberculous meningitis[J].N Engl J Med,2016,374(2):124-134.DOI:10.1056/NEJMoa1507062.
[29]ZHAO W,ZHENG M,WANG B,et al.Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo[J].Int J Infect Dis,2016,52:23-28.DOI:10.1016/j.ijid.2016.08.027.
[30]ZHANG X,FALAGAS M E,VARDAKAS K Z,et al.Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis[J].J Thorac Dis,2015,7(4):603-615.DOI:10.3978/j.issn.2072-1439.2015.03.10.
[31]KALITA J,BHOI S K,BETAI S,et al.Safety and efficacy of additional levofloxacin in tuberculous meningitis:a randomized controlled pilot study[J].Tuberculosis(Edinb),2016,98:1-6.DOI:10.1016/j.tube.2016.01.004.